Received Apr 16, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 1 | 947357 | IM / LA |
The reaction began on 03/12/26 and resolved by 03/16/26. The symptoms included itchiness, swelling, warmth, tenderness, and a glossy area approximately 4.5 inches by 2 inches, as reported by the employee.
None
None
Prenatal Vitamins (OTC)
Latex and Iodine
N/A